Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Bilopaque

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1980
Highly Cited
1980
Subsequent to studies indicating that cholecystographic agents and sulfobromophthalein (BSP) inhibit uptake of thyroxine (T(4… Expand
  • table I
  • figure 2
  • figure 3
  • figure 1
  • table II
1977
1977
The biliary and urinary excretion of sodium tyropanoate (Bilopaque) and sodium ipodate (Oragrafin) were studied in unanesthetized… Expand
1976
1976
(1) Solubilization of Telepaque in the intestine is a limiting factor in the rate of intestinal absorption. Bilopaque and… Expand
1974
1974
A double-blind technique was used in testing three cholecystographic agents in 726 patients. Graded scoring of radiographs… Expand
1974
1974
  • R. Parks
  • Radiology
  • 1974
  • Corpus ID: 29346435
Iocetamic acid (Cholebrine) in two dosage forms was compared to tyropanoate sodium (Bilopaque) and iopanoic acid (Telepaque) in… Expand
1974
1974
Time of peak visualization of the gallbladder after oral ingestion of Bilopaque (tyropanoate sodium) was studied in 50 patients… Expand
1974
1974
Cholecystography was performed in 89 consecutive patients at four-, six-, eight-, ten-, and twelve-hour intervals after ingestion… Expand
1974
1974
In 853 clinical examinations, the authors compared three cholecystographic agents: Bilopaque (tyropanoate sodium), Oragrafin… Expand
1973
1973
A double-blind comparative study of Cholebrine, 4.5 gm., and Bilopaque, 3.0 gm., was conducted in 51 patients to determine the… Expand
1963
1963
The continuing search for improved cholecystographic media has resulted in increased diagnostic accuracy and decreased clinical… Expand